USP10 and neoplasm: Luo et al. demonstrated that miR-138-5p directly targets USP10—a deubiquitinating enzyme that stabilizes both wild-type and mutant TP53, and contributes via this mechanism to both tumour suppressive and oncogenic functions [42].